Natural products for the treatment of neurodegenerative diseases
- PMID: 37778246
- DOI: 10.1016/j.phymed.2023.155101
Natural products for the treatment of neurodegenerative diseases
Abstract
Background: Neurodegenerative diseases are among the most common diseases in older adults worldwide. Alzheimer's disease (AD) and Parkinson's disease (PD) are two of the most common neurodegenerative diseases, and are accompanied by cerebral cortical atrophy, neuronal loss, protein accumulation, and excessive accumulation of metal ions. Natural products exhibit outstanding performance in improving cerebral circulatory disorders, promoting cerebral haematoma absorption, repairing damaged nerve tissue, and improving damaged nerve function. In recent years, studies have shown that neuroinflammatory mechanisms and signalling pathways closely related to the occurrence and development of neurological diseases include microglial activation, nuclear factor-κB (NF-κB) pathway, mitogen activated protein kinases (MAPK) pathway, reactive oxygen pathway, nucleotide binding oligomerisation domain-like receptor protein3 (NLRP3) inflammasomes, toll-like receptor4 (TLR4) pathway, nuclear factor erythroid 2-related factor 2 (Nrf2)/hemeoxygenase-1 (HO-1) pathway, phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway, and intestinal flora. Therefore, this study considered the mechanism of neurological diseases as the starting point to review the mechanism of action of natural products in the prevention and treatment of AD and PD in recent years to provide a theoretical basis for clinical prevention and treatment.
Aim: Natural products are a promising source of novel lead structures that have long been used to treat various nervous system diseases.
Methodology: This review collected literature on neurological diseases and natural products from 2012 to 2022, which were mainly searched through databases such as ScienceDirect, Springer, PubMed, SciFinder, China National Knowledge Infrastructure (CNKI), Wanfang, Google Scholar, and Baidu Academic. The following keywords were searched: neurological disorders, natural products, signalling pathway, mechanism of action.
Results: This review summarises the pathogenesis of degenerative neurological diseases, recent findings on natural products used in neurodegenerative diseases, and the molecular mechanisms underlying these effects.
Keywords: Mechanism of action; Natural products; Neurological disorders; Signaling pathway.
Copyright © 2023. Published by Elsevier GmbH.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease.Int J Mol Sci. 2021 Jan 28;22(3):1324. doi: 10.3390/ijms22031324. Int J Mol Sci. 2021. PMID: 33525754 Free PMC article. Review.
-
Targeting endoplasmic reticulum stress using natural products in neurological disorders.Neurosci Biobehav Rev. 2022 Oct;141:104818. doi: 10.1016/j.neubiorev.2022.104818. Epub 2022 Aug 5. Neurosci Biobehav Rev. 2022. PMID: 35940309 Review.
-
The pivotal role of JAK/STAT and IRS/PI3K signaling pathways in neurodegenerative diseases: Mechanistic approaches to polyphenols and alkaloids.Phytomedicine. 2023 Apr;112:154686. doi: 10.1016/j.phymed.2023.154686. Epub 2023 Jan 31. Phytomedicine. 2023. PMID: 36804755 Review.
-
Natural Products as the Potential to Improve Alzheimer's and Parkinson's Disease.Int J Mol Sci. 2023 May 16;24(10):8827. doi: 10.3390/ijms24108827. Int J Mol Sci. 2023. PMID: 37240173 Free PMC article. Review.
-
Shaping the Nrf2-ARE-related pathways in Alzheimer's and Parkinson's diseases.Ageing Res Rev. 2019 Sep;54:100942. doi: 10.1016/j.arr.2019.100942. Epub 2019 Aug 12. Ageing Res Rev. 2019. PMID: 31415806 Review.
Cited by
-
Paracentrotus lividus sea urchin gonadal extract mitigates neurotoxicity and inflammatory signaling in a rat model of Parkinson's disease.PLoS One. 2024 Dec 18;19(12):e0315858. doi: 10.1371/journal.pone.0315858. eCollection 2024. PLoS One. 2024. PMID: 39693313 Free PMC article.
-
Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein.Mol Neurodegener. 2025 Aug 12;20(1):90. doi: 10.1186/s13024-025-00879-0. Mol Neurodegener. 2025. PMID: 40797227 Free PMC article. Review.
-
Potential of phytochemicals in the treatment of Alzheimer disease by modulating lysosomal dysfunction: a systematic review.Chin Med. 2025 Sep 1;20(1):138. doi: 10.1186/s13020-025-01204-z. Chin Med. 2025. PMID: 40890872 Free PMC article. Review.
-
Neuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know?Brain Sci. 2023 Dec 23;14(1):19. doi: 10.3390/brainsci14010019. Brain Sci. 2023. PMID: 38248234 Free PMC article. Review.
-
Chemical Analysis and Antioxidant Activities of Resin Fractions from Pistacia lentiscus L. var. Chia in Neuroblastoma SH-SY5Y Cells.Molecules. 2025 Feb 21;30(5):997. doi: 10.3390/molecules30050997. Molecules. 2025. PMID: 40076222 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical